Back

Third generation PCSK9-inhibitors

European Heart Journal

28 August 2023
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Ulrich Laufs
Ulrich Laufs

Author

University Hospital Leipzig Leipzig , Germany

Matthias Blüher
Matthias Blüher

Author

Berend Isermann
Berend Isermann

Author

You may be interested in
thumbnail
Congress Presentation
Targeting the PCSK9 pathway: where do novel therapies fit in?
26 August 2022
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Congress Presentation
GLP1-RA associated with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources